Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.18 +0.04 (+3.90%)
As of: Sep 30, 2026 · 11:47 AM EDT

Actinium Pharmaceuticals, Inc. (ATNM) EBIT Margin (2021 - 2026)

Updated

Actinium Pharmaceuticals' EBIT Margin was 78.76% in Q2 2026.

Analysis

Actinium Pharmaceuticals, Inc. (ATNM) EBIT Margin (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actinium Pharmaceuticals' EBIT Margin was 27.23% through Jun 30, 2026; for FY2025, it came in at -40274.44%.

  • EBIT Margin shows a four-year change of -38092.28 percentage points (FY2021 to FY2025).
  • In earlier years, EBIT Margin was -64098.77% in FY2023 (-60787.70 pp), -3311.07% in FY2022 (-1128.90 pp) and -2182.17% in FY2021.
  • The Q2 2026 figure marks the highest quarterly EBIT Margin in data going back to Q1 2021.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.76%
Sep 30, 2025 -6,324.44%
Sep 30, 2022 -21,775.56%
Jun 30, 2022 -17,444.44%
Mar 31, 2022 -549.36%
Dec 31, 2021 -34,991.30%
Sep 30, 2021 -2,776.39%
Jun 30, 2021 -1,907.89%
Mar 31, 2021 -863.67%
API Access

Actinium Pharmaceuticals, Inc. EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEY